Trial Profile
Evaluation of the efficacy of Symbicort turbuhaler in patients with bronchial asthma complicated by COPD and bronchial asthma - Evaluation of diurnal variation in peak flow
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 Apr 2012 New trial record